DHR vs TMO: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and Thermo Fisher Scientific Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-10.
Danaher Corporation · Healthcare
$195.98
+7.9% upside to fair value
Grade B
High Quality
VS
Thermo Fisher Scientific Inc. · Healthcare
$464.61
+7.2% upside to fair value
Grade A
High Quality
QuantHub Verdict
DHR has more upside to fair value
(+7.9%).
TMO trades at a lower forward P/E
(25.2x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
TMO |
| Current Price |
$195.98 |
$464.61 |
| Fair Value Estimate |
$211.54 |
$498.27 |
| Upside to Fair Value |
+7.9%
|
+7.2%
|
| Market Cap |
$138.7B |
$172.7B |
| Forward P/E |
37.8x
|
25.2x
|
| EV / EBITDA |
22.8x
|
19.1x
|
| Price / Sales |
5.6x
|
3.8x
|
| Price / FCF |
26.2x
|
25.6x
|
| Revenue Growth YoY |
+3.7%
|
+6.2%
|
| Gross Margin |
60.7%
|
39.4%
|
| Operating Margin |
21.0%
|
17.8%
|
| Return on Equity |
7.1%
|
13.3%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
3.81%
|
3.91%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Danaher Corporation operates in the healthcare sector, specifically in medical diagnostics and research, delivering high-quality products with a durable competitive moat supported by strong margins and consistent earnings growth. The company trades at a trailing and forward P/E of 37.76, which is relatively high but justified by its stable revenue growth of 3.7% and earnings growth of 7.9% in the…
Thermo Fisher Scientific is a leading healthcare company specializing in life science tools, diagnostics, and contract research and manufacturing services. It operates with a broad, multi-layered moat driven by scale, integration, and a long-tenured management team. The company exhibits solid fundamentals with a 13.3% ROE, 6.2% revenue growth, and 9.6% earnings growth in the most recent quarter. …
Accumulation Zones
| Metric |
DHR |
TMO |
| Zone Low |
$158.66 |
$373.70 |
| Zone High |
$179.81 |
$423.53 |
| In Buy Zone? |
No
|
No
|